First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,345 · see citing works

Identification of a new human coronavirus

van der Hoek, L., Pyrć, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Dillen, P. M. E. W., Kaandorp, J. C., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,868 · see citing works

Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

Woo, P. C. Y., Lau, S. K. P., Chu, C., Chan, K., Tsoi, H., Huang, Y. P., Wong, B. H. L., Poon, R. W., Cai, J. J., Luk, W., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525 · see citing works

A New Virus Isolated from the Human Respiratory Tract.

Hamre, D. M., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 888 · see citing works

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824 · see citing works

Coronavirus Genome Structure and Replication

Brian, D. A., & Baric, R. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-26765-4_1 · Cited by 758 · see citing works

Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method

Gaunt, E. R., Hardie, A., Claas, E. C. J., Peter Simmonds, K., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699 · see citing works

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688 · see citing works

Cultivation of a Novel Type of Common-cold Virus in Organ Cultures

Tyrrell, D. A. J., & Bynoe, M. L. (1965) · BMJ · doi:10.1136/bmj.1.5448.1467 · Cited by 623 · see citing works

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598 · see citing works

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012

Bermingham, A., Chand, M. A., Brown, C. S., Aarons, E., Tong, C. Y. W., Langrish, C., Höschler, K., Brown, K. E., Galiano, M., Myers, R. E., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.40.20290-en · Cited by 468 · see citing works

Human Coronavirus Infections in Rural Thailand: A Comprehensive Study Using Real‐Time Reverse‐Transcription Polymerase Chain Reaction Assays

Dare, R. K., Fry, A. M., Chittaganpitch, M., Sawanpanyalert, P., Olsen, S. J., & Erdman, D. D. (2007) · The Journal of Infectious Diseases · doi:10.1086/521308 · Cited by 333 · see citing works

Effects of a "new" human respiratory virus in volunteers.

Bradburne, A. F., Bynoe, M. L., & Tyrrell, D. A. J. (1967) · BMJ · doi:10.1136/bmj.3.5568.767 · Cited by 304 · see citing works

Human Coronavirus NL63 and 229E Seroconversion in Children

Dijkman, R., Jebbink, M. F., Idrissi, N. B. E., Pyrć, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L., & van der Hoek, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-08 · Cited by 177 · see citing works

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Gorse, G. J., Patel, G. B., Vitale, J. N., & O’Connor, T. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00278-10 · Cited by 165 · see citing works

A Prospective Hospital‐Based Study of the Clinical Impact of Non–Severe Acute Respiratory Syndrome (Non‐SARS)–Related Human Coronavirus Infection

Garbino, J., Crespo, S., Aubert, J., Rochat, T., Ninet, B., Deffernez, C., Wunderli, W., Pache, J., Soccal, P. M., & Kaiser, L. (2006) · Clinical Infectious Diseases · doi:10.1086/507898 · Cited by 135 · see citing works

Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia

Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Tsoi, H.-W., Fung, A. M. Y., Kao, R. Y. T., Chan, K., Peiris, M. J. S., & Yuen, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3054-3058.2005 · Cited by 126 · see citing works

Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation

Zhang, L., Nolan, E. F., Kreitschitz, S., & Rabussay, D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00270-2 · Cited by 118 · see citing works

Effects of Coronavirus Infections in Children

Principi, N., Bosis, S., & Esposito, S. (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090469 · Cited by 109 · see citing works

Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population

Severance, E. G., Bossis, I., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Yolken, R. H., & Viscidi, R. P. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00124-08 · Cited by 101 · see citing works

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus

Chan, C.-M., Tse, H., Wong, S. S. Y., Woo, P. C. Y., Lau, S. K. P., Chen, L., Zheng, B. J., Huang, J., & Yuen, K. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.02.011 · Cited by 92 · see citing works

Coronavirus antibody titres in sera of healthy adults and experimentally infected volunteers

Bradburne, A. F., & Somerset, B. A. (1972) · Journal of Hygiene · doi:10.1017/s0022172400022294 · Cited by 81 · see citing works

Seroepidemiology of group I human coronaviruses in children

Shao, X., Guo, X., Esper, F. P., Weibel, C., & Kahn, J. S. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.08.007 · Cited by 67 · see citing works

Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E

Kraaijeveld, C. A., Reed, S. E., & Macnaughton, M. R. (1980) · Journal of Clinical Microbiology · doi:10.1128/jcm.12.4.493-497.1980 · Cited by 59 · see citing works

Update on Rhinovirus and Coronavirus Infections

Greenberg, S. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1283283 · Cited by 59 · see citing works

False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV

Maache, M., Komurian-Pradel, F., Rajoharison, A., Perret, M., Berland, J., Pouzol, S., Bagnaud, A., Duverger, B., Xu, J., Osuna, A., et al. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.3.409-414.2006 · Cited by 40 · see citing works

A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses

Lehmann, C., Wolf, H. J., Xu, J., Zhao, Q., Shao, Y., Motz, M., & Lindner, P. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.12.002 · Cited by 28 · see citing works

Prevalence of human coronavirus antibody in the population of southern iraq

Hasony, H. J., & Macnaughton, M. R. (1982) · Journal of Medical Virology · doi:10.1002/jmv.1890090308 · Cited by 26 · see citing works

Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins

Haynes, L. M., Miao, C., Harcourt, J. L., Montgomery, J. M., Le, M. Q., Dryga, S. A., Kamrud, K. I., Rivers, B., Babcock, G. J., Oliver, J. B., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00351-06 · Cited by 24 · see citing works

Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody

Giménez, L., Rojas, J., Rojas, A., Mendoza, J., & Camacho, A. G. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00252-08 · Cited by 9 · see citing works

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026 · see citing works

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767 · see citing works

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437 · see citing works

Immunological characteristics govern the transition of COVID-19 to endemicity

Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416 · see citing works

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S. M., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 299 · see citing works

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265 · see citing works

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J. H., Obiero, J. M., Norris, P. J., Stone, M., Simmons, G., Bagri, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20095-2 · Cited by 201 · see citing works

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016) · Scientific Reports · doi:10.1038/srep22677 · Cited by 185 · see citing works

Identification of New Respiratory Viruses in the New Millennium

Berry, M. J., Gamieldien, J., & Fielding, B. C. (2015) · Viruses · doi:10.3390/v7030996 · Cited by 163 · see citing works

Molecular Basis of Coronavirus Virulence and Vaccine Development

Enjuanes, L., Zúñiga, S., Castaño-Rodríguez, C., Gutierrez-Alvarez, F. J., Cantón, J., & Sola, I. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.003 · Cited by 158 · see citing works

Direct Observation of Repeated Infections With Endemic Coronaviruses

Galanti, M., & Shaman, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa392 · Cited by 149 · see citing works

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Carbajo-Lozoya, J., Ma‐Lauer, Y., Malešević, M., Theuerkorn, M., Kahlert, V., Prell, E., von Brunn, B., Muth, D., Baumert, T. F., Drosten, C., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.010 · Cited by 136 · see citing works

Convalescent Plasma Therapy for COVID-19: State of the Art

Focosi, D., Anderson, A. O., Tang, J. W.-T., & Tuccori, M. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-20 · Cited by 123 · see citing works

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe, A., Kronsteiner, B., Skelly, D., Pace, M. J., Brown, A., Adland, E., Adair, K., Akhter, H. D., Ali, M., Ali, S.-E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21856-3 · Cited by 121 · see citing works

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen MicroarrayPreprint

Khan, S., Nakajima, R., Jain, A., de Assis, R. R., Jasinskas, A., Obiero, J. M., Adenaiye, O., Tai, S., Hong, F. H., Milton, D. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.24.006544 · Cited by 118 · see citing works

Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines

Zheng, Y., Li, R., & Liu, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26009 · Cited by 105 · see citing works

Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity

Aguilar-Bretones, M., Fouchier, R. A. M., Koopmans, M., & van Nierop, G. P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162192 · Cited by 104 · see citing works

Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective

Li, D., & Li, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02160-20 · Cited by 92 · see citing works

SARS-CoV-2 antibody testing—questions to be asked

Özcürümez, M. K., Ambrosch, A., Frey, O., Haselmann, V., Holdenrieder, S., Kiehntopf, M., Neumaier, M., Walter, M., Wenzel, F., Wölfel, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.020 · Cited by 82 · see citing works

Robust and durable serological response following pediatric SARS-CoV-2 infection

Renk, H., Dulovic, A., Seidel, A., Becker, M., Fabricius, D., Zernickel, M., Junker, D., Groß, R. M., Müller, J. A., Hilger, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27595-9 · Cited by 81 · see citing works

Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age

Humbert, M., Olofsson, A., Wullimann, D., Niessl, J., Hodcroft, E. B., Cai, C., Gao, Y., Sohlberg, E., Dyrdak, R., Mikaeloff, F., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220320120 · Cited by 71 · see citing works

Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study

Berry, M. J., Fielding, B. C., & Gamieldien, J. (2015) · Viruses · doi:10.3390/v7122963 · Cited by 67 · see citing works

Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020

Sermet‐Gaudelus, I., Temmam, S., Huon, C., Behillil, S., Gajdos, V., Bigot, T., Lurier, T., Chrétien, D., Backović, M., Delaunay, A., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.13.2001782 · Cited by 67 · see citing works

Immunoreactive peptide maps of SARS-CoV-2

Mishra, N., Huang, X., Joshi, S., Guo, C., Ng, J., Thakkar, R., Wu, Y., Dong, X., Li, Q., Pinapati, R. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01743-9 · Cited by 65 · see citing works

Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?

Hamady, A., Lee, J., & Loboda, Z. (2021) · Infection · doi:10.1007/s15010-021-01664-z · Cited by 65 · see citing works

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

Woudenberg, T., Pelleau, S., Anna, F., Attia, M., Donnadieu, F., Gravet, A., Lohmann, C., Séraphin, H., Guihéneuf, R., Delamare, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103495 · Cited by 63 · see citing works

Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

Beretta, A., Cranage, M. P., & Zipeto, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.567710 · Cited by 56 · see citing works

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

Majdoubi, A., Michalski, C., O’Connell, S. E., Dada, S., Narpala, S., Gelinas, J. P., Mehta, D., Cheung, C., Winkler, D. F. H., Basappa, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146316 · Cited by 56 · see citing works

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Siggins, M. K., Thwaites, R. S., & Openshaw, P. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.016 · Cited by 56 · see citing works

Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19

Elkodous, M. A., Olojede, S. O., Morsi, M., & El-Sayyad, G. S. (2021) · RSC Advances · doi:10.1039/d1ra04835j · Cited by 55 · see citing works

Role of the humoral immune response during COVID-19: guilty or not guilty?

Yaugel-Novoa, M., Bourlet, T., & Paul, S. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00569-w · Cited by 53 · see citing works

Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1

Qian, Z., Ou, X., Góes, L. G. B., Osborne, C. M., Castano, A. M., Holmes, K. V., & Dominguez, S. R. (2015) · Journal of Virology · doi:10.1128/jvi.03737-14 · Cited by 52 · see citing works

Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients

Soleimani, R., Khourssaji, M., Gruson, D., Rodriguez‐Villalobos, H., Berghmans, M., Belkhir, L., Yombi, J. C., & Kabamba‐Mukadi, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26430 · Cited by 52 · see citing works

Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes

Wang, C., Hesketh, E. L., Shamorkina, T. M., Li, W., Franken, P. J., Drabek, D., van Haperen, R., Townend, S., van Kuppeveld, F. J. M., Grosveld, F. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30658-0 · Cited by 51 · see citing works

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 44 · see citing works

Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations

Cohen, L., Spiro, D. J., & Viboud, C. G. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010591 · Cited by 41 · see citing works

Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults

Tamminen, K., Salminen, M., & Blazevic, V. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108782 · Cited by 37 · see citing works

Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020

Dyrdak, R., Hodcroft, E. B., Wahlund, M., Neher, R. A., & Albert, J. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104754 · Cited by 34 · see citing works

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection

Jacob-Dolan, C., Feldman, J. E., McMahan, K., Yu, J., Zahn, R. C., Wegmann, F., Schuitemaker, H., Schmidt, A. G., & Barouch, D. H. (2021) · Journal of Virology · doi:10.1128/jvi.00117-21 · Cited by 31 · see citing works

Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland

Ulytė, A., Radtke, T., Abela, I. A., Haile, S. R., Blankenberger, J., Jung, R., Capelli, C., Berger, C., Frei, A. L., Huber, M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047483 · Cited by 31 · see citing works

Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans

Alves, D., Curvello, R., Henderson, E. C., Kesarwani, V., Walker, J. A., Leguizamon, S., McLiesh, H., Raghuwanshi, V. S., Samadian, H., Wood, E. M., et al. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01050 · Cited by 30 · see citing works

Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1

Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Diamandis, E. P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9902 · Cited by 29 · see citing works

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort

Smith, M., Abdesselem, H., Mullins, M. O., Tan, T.-M., Nel, A. J. M., Al‐Nesf, M. A., Bensmail, I., Majbour, N. K., Vaikath, N. N., Naik, A., et al. (2021) · Viruses · doi:10.3390/v13050786 · Cited by 27 · see citing works

Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity

Lehmann, A. A., Kirchenbaum, G. A., Zhang, T., Reche, P. A., & Lehmann, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635942 · Cited by 27 · see citing works

The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development

Wang, J., & Zand, M. S. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.39 · Cited by 26 · see citing works

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19

Gregory, D. J., Vannier, A., Duey, A. H., Roady, T. J., Dzeng, R. K., Pavlovic, M., Chapin, M. H., Mukherjee, S., Wilmot, H., Chronos, N., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2073025 · Cited by 23 · see citing works

Immunological imprinting of humoral immunity to SARS-CoV-2 in children

Dowell, A. C., Lancaster, T., Bruton, R. K., Ireland, G., Bentley, C., Sylla, P., Zuo, J., Scott, S., Jadir, A., Begum, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39575-2 · Cited by 23 · see citing works

Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population

Dijkstra, J. M., & Hashimoto, K. (2020) · F1000Research · doi:10.12688/f1000research.23458.1 · Cited by 20 · see citing works

Evolutionary medical insights into the SARS-CoV-2 pandemic

Crespi, B. J. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa036 · Cited by 20 · see citing works

Initial Determination of COVID-19 Seroprevalence Among Outpatients and Healthcare Workers in Minnesota Using a Novel SARS-CoV-2 Total Antibody ELISA

Thomas, S. N., Altawallbeh, G., Zaun, C. P., Pape, K. A., Peters, J. M., Titcombe, P. J., Dileepan, T., Rapp, M. J., Bold, T. D., Schacker, T. W., et al. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.01.010 · Cited by 20 · see citing works

Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19

Pinotti, F., Wikramaratna, P. S., Obolski, U., Paton, R. S., Damineli, D. S. C., Alcântara, L. C. J., Giovanetti, M., Gupta, S., & Lourenço, J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01887-1 · Cited by 19 · see citing works

Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines

Sayama, Y., Okamoto, M., Saito, M., Saito‐Obata, M., Tamaki, R., Joboco, C. D., Lupisan, S., & Oshitani, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-29072-3 · Cited by 19 · see citing works

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

Mahalingam, S., Peter, J., Xu, Z., Bordoloi, D., Ho, M., Kalyanaraman, V. S., Srinivasan, A., & Muthumani, K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06836 · Cited by 19 · see citing works

Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts

Bortz, R. H., Florez, C., Laudermilch, E., Wirchnianski, A. S., Lasso, G., Malonis, R. J., Georgiev, G. I., Vergnolle, O., Herrera, N. G., Morano, N. C., et al. (2021) · mSphere · doi:10.1128/msphere.00224-21 · Cited by 19 · see citing works

Adaptive immunity to human coronaviruses is widespread but low in magnitude

Tan, H., Lee, W. S., Wragg, K. M., Nelson, C., Esterbauer, R., Kelly, H. G., Amarasena, T. H., Jones, R. M., Starkey, G., Wang, B. Z., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1264 · Cited by 18 · see citing works

Five reasons COVID-19 is less severe in younger age-groups

Turke, P. W. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa050 · Cited by 17 · see citing works

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada

Tanunliong, G., Liu, A. C., Kaweski, S. E., Irvine, M. A., Reyes, R. C., Purych, D., Krajden, M., Morshed, M. G., Sekirov, I., Gantt, S. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836449 · Cited by 16 · see citing works

Recent advances in immunoassay technologies for the detection of human coronavirus infections

Wang, D., Chen, Y., Shan, X., Hu, H., Zhan, Y., Yu, Y., Zhang, J., Wu, P., Liu, F. Y., Kai, T., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1040248 · Cited by 16 · see citing works

From conifers to cognition: Microbes, brain and behavior

Lathe, R., & Clair, D. S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12680 · Cited by 16 · see citing works

Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies

Garritsen, A., Scholzen, A., van den Nieuwenhof, D. W. A., Smits, A. P. F., Datema, E. S., van Galen, L. S., & Kouwijzer, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1893378 · Cited by 15 · see citing works

Seroprevalence of human coronaviruses among patients visiting hospital-based sentinel sites in Uganda

Mulabbi, E. N., Tweyongyere, R., Wabwire‐Mangen, F., Mworozi, E. A., Koehlerb, J., Kibuuka, H. N., Millard, M., Erima, B., Tugume, T., Ukuli, Q. A., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06258-6 · Cited by 14 · see citing works

Endemic Non–SARS-CoV-2 Human Coronaviruses in a Community-Based Australian Birth Cohort

Grimwood, K., Lambert, S. B., & Ware, R. S. (2020) · PEDIATRICS · doi:10.1542/peds.2020-009316 · Cited by 14 · see citing works

Convalescent Plasma Therapy for Covid-19: State of the ArtPreprint

Focosi, D., Tang, J. W.-T., Anderson, A., & Tuccori, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0097.v7 · Cited by 12 · see citing works

Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections

Sechan, F., Grobben, M., Edridge, A. W. D., Jebbink, M. F., Loens, K., Ieven, M. M., Goossens, H., van Hemert-Glaubitz, S., van Gils, M. J., & van der Hoek, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.853410 · Cited by 11 · see citing works

Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination

Yin, D., Han, Z., Lang, B., Li, Y., Mai, G., Chen, H., Feng, L., Chen, Y.-Q., Luo, H., Xiong, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195533 · Cited by 11 · see citing works

Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France

Colson, P., Esteves-Vieira, V., Giraud‐Gatineau, A., Zandotti, C., Filosa, V., Chaudet, H., Lagier, J., & Raoult, D. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1417 · Cited by 11 · see citing works

Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera

Deschermeier, C., Ehmen, C., von Possel, R., Murawski, C., Rushton, B., Amuasi, J., Sarpong, N., Maïga‐Ascofaré, O., Rakotozandrindrainy, R., Asogun, D., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00075-22 · Cited by 10 · see citing works

SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children

Frutos, A. M., Kubale, J., Kuan, G., Ojeda, S., Vydiswaran, N., Sánchez, N., Plazaola, M., Patel, M., López, R., Balmaseda, Á., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000414 · Cited by 10 · see citing works

Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2

Denninger, V., Xu, C. K., Meisl, G., Morgunov, A. S., Fiedler, S., Ilsley, A., Emmenegger, M., Malik, A. Y., Piziorska, M. A., Schneider, M. M., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00486 · Cited by 10 · see citing works

Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood

Kolehmainen, P., Heroum, J., Jalkanen, P., Huttunen, M., Toivonen, L., Marjomäki, V., Waris, M. E., Smura, T., Kakkola, L., Tauriainen, S., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01967-21 · Cited by 10 · see citing works

Analysis of the application value of serum antibody detection for staging of COVID‐19 infection

Zheng, Y., Yan, M., Wang, L., Luan, L., Liu, J., Tian, X. Y., & Wan, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26330 · Cited by 9 · see citing works

Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children

Li, N., Li, X., Wu, J., Zhang, S., Zhu, L., Chen, Q., Fan, Y., Wu, Z., Xie, S., Chen, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1042406 · Cited by 9 · see citing works

Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers

Kolehmainen, P., Huttunen, M., Iakubovskaia, A., Maljanen, S., Tauriainen, S., Yatkin, E., Pasternack, A. H., Naves, R. A., Toivonen, L., Tähtinen, P. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35471-3 · Cited by 9 · see citing works

Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses

Dijkstra, J. M., Frenette, A. P., & Dixon, B. (2021) · F1000Research · doi:10.12688/f1000research.51479.1 · Cited by 9 · see citing works

Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China

Bai, Z., Li, Q., Chen, Q., Niu, C., Wei, Y., Huang, H., Zhao, W., Chen, N., Yao, X., Zhang, Q., et al. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.09.001 · Cited by 8 · see citing works

Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies

Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.1 · Cited by 8 · see citing works

Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection

Dowell, A. C., Tut, G., Begum, J., Bruton, R. K., Bentley, C., Butler, M., Uwenedi, G., Zuo, J., Powell, A. A., Brent, A., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.08.013 · Cited by 7 · see citing works

Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic

Kakuya, F., Terao, R., Onoda, H., Okubo, H., Fujiyasu, H., INYAKU, F., Fukuura, A., Arai, T., & Kinebuchi, T. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.11.012 · Cited by 7 · see citing works

Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2

Stocking, C. J., de Miguel, L., Suteu, G., Dressel, A., Soricelli, A., Roskos, M., Valor, S., Mutschmann, C., & März, W. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115587 · Cited by 6 · see citing works

Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic

Schubl, S. D., Figueroa, C. J., Palma, A. M., de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Brabender, D. E., Hosseinian, S., Naaseh, A., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08284-y · Cited by 6 · see citing works

Convalescent Plasma Therapy for Covid-19: State of the ArtPreprint

Focosi, D., Tang, J. W.-T., Anderson, A. O., & Tuccori, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0097.v5 · Cited by 6 · see citing works

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies

Wong, L. S. Y., Loo, E. X. L., Huang, C., Yap, G. C., Tay, M. J. Y., Chua, R. X. Y., Kang, A. Y. H., Lu, L., Lee, B. W., Shek, L. P., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.08.032 · Cited by 6 · see citing works

Burden and seasonality of primary and secondary symptomatic common cold coronavirus infections in Nicaraguan children

Frutos, A. M., Balmaseda, Á., Vydiswaran, N., PATEL, M. J., Ojeda, S., Brouwer, A. F., Tutino, R. C., Cai, S., Bakker, K. M., Sánchez, N., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13086 · Cited by 5 · see citing works

Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics

Erlichster, M., Chana, G., Zantomio, D., Goudey, B., & Skafidas, E. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1028 · Cited by 5 · see citing works

Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron

Gerges, D., Kapps, S., Hernández-Carralero, E., Freire, R., Aiad, M., Schmidt, S., Winnicki, W., Reiter, T., Pajenda, S., Schmidt, A., et al. (2022) · Viruses · doi:10.3390/v14061181 · Cited by 5 · see citing works

Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China

Luo, Y., Lv, H., Zhao, S., Sun, Y., Liu, C.-Y., Chen, C., Liang, W., Kwok, K. O., Teo, Q. W., So, R. T. Y., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.044 · Cited by 4 · see citing works

Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors

Lobaina, Y., Chen, R., Ai, P., Yang, L.-L., Alvarez‐Lajonchere, L., Suzarte, E., Tan, C., Silva, R., Jiang, Z., Yang, K., et al. (2023) · Viral Immunology · doi:10.1089/vim.2022.0186 · Cited by 4 · see citing works

SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses

van der Hoek, L. (2020) · Med · doi:10.1016/j.medj.2020.12.005 · Cited by 4 · see citing works

Crystal structures of human coronavirus NL63 main protease at different pH values

Gao, H., Zhang, Y., Jiang, H., Hu, X., Zhang, Y., Zhou, X., Zhong, F., Lin, C., Li, J., Luo, J., et al. (2021) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x21009523 · Cited by 4 · see citing works

DETECTION OF SPECIFIC ANTIBODIES TO THE NUCLEOCAPSID PROTEIN FRAGMENTS OF SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS AND SCOTOPHILUS BAT CORONAVIRUS-512 IN THREE INSECTIVOROUS BAT SPECIES

Chen, Y., Su, B.-G., Chen, H., Chou, C., & Cheng, H.-C. (2018) · Taiwan Veterinary Journal · doi:10.1142/s1682648518500063 · Cited by 4 · see citing works

Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19

LaCourse, C. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100905 · Cited by 3 · see citing works

NUEVOS VIRUS RESPIRATORIOS EN PEDIATRÍA

Inostroza, E., & Pinto, R. A. (2017) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2017.01.005 · Cited by 3 · see citing works

Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies

Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.3 · Cited by 3 · see citing works

Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD AntibodiesPreprint

Curtis, N. C., Shin, S., Hederman, A. P., Connor, R. I., Wieland‐Alter, W., Ionov, S., Boylston, J. A., Rose, J., Sakharkar, M., Dorman, D. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556349 · Cited by 3 · see citing works

High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines

Joseph, J. O., Ylade, M. C., Daag, J. V., Aogo, R. A., Crisostomo, M. V., Mpingabo, P. I., Premkumar, L., Deen, J. L., & Katzelnick, L. C. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09672-8 · Cited by 2 · see citing works

Antibody Responses Against SARS-Cov-2 in COVID-19 and Serological Assays

Çakal, B. (2020) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2020-76285 · Cited by 2 · see citing works

Dynamics and Determinants of SARS-CoV-2 RT-PCR Testing on Symptomatic Individuals Attending Healthcare Centers during 2020 in Bahia, Brazil

Pereira, F. M., de Araujo, A. S., Reis, A. C. M., da Hora, A. S., Pinotti, F., Paton, R. S., Figueiredo, C. V. B., Damasceno, C. L., dos Santos, D. C., de Santana, D. S., et al. (2022) · Viruses · doi:10.3390/v14071549 · Cited by 2 · see citing works

Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers

Hatabah, D., Gupta, S. L., Mantus, G. E., Sullivan, P. S., Heilman, S. S., Camacho-González, A., Leake, D., Le, U. Q., Griffiths, M., Norwood, C., et al. (2025) · Vaccines · doi:10.3390/vaccines13020163 · Cited by 1 · see citing works

Serological analyses against endemic human coronaviruses and SARS-CoV-2 in children and adults using samples collected before the COVID-19 pandemic

Sayama, Y., Lo, C., Tomizawa, H., Saito, M., Okamoto, M., Ohmiya, S., Nishimura, H., & Oshitani, H. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.100485 · Cited by 1 · see citing works

SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemic

Gonzalez‐Lopez, C., Aguilar-Bretones, M., Reinders, J., Zhang, J., van den Doel, P., Bekki, B., Gorp, E. C. M. V., van der Kuy, P. H. M., Haagmans, B. L., GeurtsvanKessel, C. H., et al. (2026) · npj Viruses · doi:10.1038/s44298-026-00185-6 · Cited by 1 · see citing works

Serological analyses against endemic human coronaviruses and SARS-CoV-2 in children and adults using samples collected before the COVID-19 pandemic

Sayama, Y., Lo, C., Tomizawa, H., Saito, M., Okamoto, M., Ohmiya, S., Nishimura, H., & Oshitani, H. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.100485 · Cited by 1 · see citing works

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France

Thoisy, A. D., Woudenberg, T., Pelleau, S., Donnadieu, F., García, L., Pinaud, L., Tondeur, L., Meola, A., Arowas, L., Clement, N., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad340 · Cited by 19 · see citing works

Seroprevalence of prior infections of common human coronaviruses in children in Southwestern Pennsylvania and the associations between race, sex and age on seropositivity

Ji, L. (2022) · D-Scholarship@Pitt (University of Pittsburgh)

Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China

Luo, Y., Lv, H., Zhao, S., Sun, Y., Liu, C.-Y., Chen, C., Liang, W., Kwok, K. O., Teo, Q. W., So, R. T. Y., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.044 · Cited by 4 · see citing works

Seroepidemiology of group I human coronaviruses in children

Shao, X., Guo, X., Esper, F. P., Weibel, C., & Kahn, J. S. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.08.007 · Cited by 67 · see citing works